Fox Run Management, L.L.C. Sorrento Therapeutics, Inc. Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$2.0 - $4.9 $29,402 - $72,034	-14,701 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$4.65 - $7.23 $68,359 - $106,288	14,701 New	14,701 $68,000
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $95,875 - $225,163	-13,638 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$5.76 - $11.95 $78,554 - $162,974	13,638 New	13,638 $93,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.